Dr. Abrams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave
Dana 1220
Boston, MA 02115Phone+1 617-632-6932Fax+1 617-632-5370- Is this information wrong?
Education & Training
University of Michigan Health SystemFellowship, Hematology and Medical Oncology, 2003 - 2006- University of Michigan Health SystemResidency, Internal Medicine, 2000 - 2003
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2000
Certifications & Licensure
MA State Medical License 2006 - 2025
FL State Medical License 2016 - 2018
NH State Medical License 2010 - 2018
MI State Medical License 2000 - 2008- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer Start of enrollment: 2009 Jun 01
- Sorafenib + mFOLFOX for Hepatocellular Carcinoma Start of enrollment: 2013 Jan 01
- HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC) Start of enrollment: 2013 May 01
- Join now to see all
Publications & Presentations
PubMed
- RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer.Harshabad Singh, Pranshu Sahgal, Kevin Kapner, Steven M Corsello, Hersh Gupta, Rahul Gujrathi, Yvonne Y Li, Andrew D Cherniack, Raquelle El Alam, Joseph Kerfoot, Eliza...> ;Clinical Cancer Research. 2024 Apr 15
- PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer.Ali, L., Lenehan, P., Cardot-Ruffino, V., Dias Costa, A., Katz, M., Bauer, T., Nowak, J., Wolpin, B., Abrams, T., Patel, A., Clancy, T., Wang, J., Mancias, J., Reilley...> ;Clinical Cancer Research. 2024 Feb 1
- Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders.Huffman, B., Singh, H., Ali, L., Horick, N., Wang, S., Hoffman, M., Metayer, K., Murray, S., Bird, A., Abrams, T., Biller, L., Chan, J., Meyerhardt, J., McCleary, N., ...> ;Journal for Immunotherapy of Cancer. 2024 Jan 25
- Join now to see all
Press Mentions
Exelixis Announces Detailed Results for Cabozantinib in Combination with Immunotherapies in Patients with Advanced Colorectal Cancer at ASCO GI 2022January 18th, 2022
New Paradigm Emerging in Advanced Pancreatic CancerMay 25th, 2016- Partnering With Patients: A Collection of Perspectives From ASCO 2023September 7th, 2023
Committees
- Member, National Comprehensive Cancer Network (NCCN) Hepatobiliary Cancers Guidelines Committee 2008 - Present
Professional Memberships
- Member
Hospital Affiliations
Brigham and Women's HospitalBoston, Massachusetts
Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
